47th week of 2020 patent applcation highlights part 10 |
Patent application number | Title | Published |
20200360442 | MESENCHYMAL STEM CELLS AND USES THEREFOR | 2020-11-19 |
20200360443 | STEM CELL MATERIAL AND METHOD OF MANUFACTURING | 2020-11-19 |
20200360444 | CELL POPULATION INCLUDING ADHESIVE STEM CELLS, PRODUCTION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION | 2020-11-19 |
20200360445 | ACELLULAR BIOLOGIC COMPOSITION AND METHOD OF MANUFACTURE | 2020-11-19 |
20200360446 | PRESERVATION OF PANCREATIC ISLET GRAFTS IN THE EXTRAHEPATIC SPACE | 2020-11-19 |
20200360447 | METHOD FOR PRODUCING MARINE ALGAE-DERIVED AGAROTRIOSE, AND USE THEREOF AS PREBIOTIC | 2020-11-19 |
20200360448 | Fructophilic lactic acid producing bacteria | 2020-11-19 |
20200360449 | MICROBIOTA COMPOSITION, AS A MARKER OF RESPONSIVENESS TO CHEMOTHERAPY, AND USE OF MICROBIAL MODULATORS (PRE-, PRO- OR SYNBIOTICS) FOR IMPROVING THE EFFICACY OF A CANCER TREATMENT | 2020-11-19 |
20200360450 | TREATMENT OF LIVER DISEASE BY MODULATION OF THE MICROBIOME | 2020-11-19 |
20200360451 | FERMENTED MILK FOR IMPROVING AUTONOMIC FUNCTION | 2020-11-19 |
20200360452 | HEALTH BENEFICIAL COMPOSITION COMPRISING LACTOBACILLUS AND METHOD FOR THE PREPARATION THEREOF | 2020-11-19 |
20200360453 | METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY TO VIRAL TRANSFER VECTORS | 2020-11-19 |
20200360454 | Gene Editing to Impove Joint Function | 2020-11-19 |
20200360455 | COMPOSITION FOR IMPROVING PHYSICAL STRENGTH OR ATHLETIC ABILITY, CONTAINING NUTMEG EXTRACT AS ACTIVE INGREDIENT | 2020-11-19 |
20200360456 | METHOD FOR PROCESSING GINSENG WITH ULTRA-HIGH PRESSURE | 2020-11-19 |
20200360457 | ROOT EXTRACTS FROM PLANTS OF THE MORUS GENUS AND USES OF SAME | 2020-11-19 |
20200360458 | HEALTH FUNCTIONAL FOOD FOR INHIBITING RISE OF BLOOD GLUCOSE CONTAINING COFFEE AND TAGATOSE | 2020-11-19 |
20200360459 | NATURAL DRUGS FOR THE TREATMENT OF INFLAMMATION AND MELANOMA | 2020-11-19 |
20200360460 | NEUROPROTECTIVE PEPTIDE | 2020-11-19 |
20200360461 | ORODISPERSIBLE FILM COMPOSITION COMPRISING ENALAPRIL FOR THE TREATMENT OF HYPERTENSION IN A PEDIATRIC POPULATION | 2020-11-19 |
20200360462 | METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH | 2020-11-19 |
20200360463 | Materials and Methods for Treatment of Inflammation | 2020-11-19 |
20200360464 | METHOD OF ENHANCING THE THERAPEUTIC EFFICACY OF FEXAPOTIDE TRIFLUTATE IN TREATING LUTS | 2020-11-19 |
20200360467 | TARGETING G3BP PROTEINS TO ACCELERATE NERVE REGENERATION | 2020-11-19 |
20200360468 | METHODS OF DIAGNOSIS, SELECTION, AND TREATMENT OF DISEASES AND CONDITIONS CAUSED BY OR ASSOCIATED WITH METHANOGENS | 2020-11-19 |
20200360469 | BRAF-BASED POLYPEPTIDES FOR TREATMENT OF CANCER | 2020-11-19 |
20200360470 | COMPOSITION COMPRISING AN ALGAL PROTEOGLYCAN EXTRACT AND USE THEREOF | 2020-11-19 |
20200360471 | METHODS OF TREATING AND PREVENTING VIRAL INFECTIONS | 2020-11-19 |
20200360472 | COMPOSITIONS AND METHODS FOR TREATING MOTOR NEURON DISEASES | 2020-11-19 |
20200360473 | ANTICOAGULANT PROTEINS AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH THE ACTIVATION OF NEUTROPHILS | 2020-11-19 |
20200360474 | RECEPTOR-BASED ANTAGONISTS OF THE PROGRAMMED CELL DEATH 1 (PD-1) PATHWAY | 2020-11-19 |
20200360475 | METHODS FOR DOSING AN ACTRIIB ANTAGONIST AND MONITORING OF TREATED PATIENTS | 2020-11-19 |
20200360476 | TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE | 2020-11-19 |
20200360477 | INHALABLE FORMULATIONS FOR KINASE INHIBITION | 2020-11-19 |
20200360478 | GPCR HETEROMER INHIBITORS AND USES THEREOF | 2020-11-19 |
20200360479 | ENGINEERED CCL20 LOCKED DIMER POLYPEPTIDE | 2020-11-19 |
20200360480 | METHOD OF TREATING IDIOPATHIC THROMBOCYTOPENIA PURPURA (ITP) WITH ROMIPLOSTIM | 2020-11-19 |
20200360481 | USE OF MRNAS ENCODING OX40L, IL-23 AND IL-36gamma IN COMBINATION WITH IMMUNE CHECKPOINT BLOCKADE FOR TREATING CANCER | 2020-11-19 |
20200360482 | CARRIER-FREE BIOLOGICALLY-ACTIVE PROTEIN NANOSTRUCTURES | 2020-11-19 |
20200360483 | METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUE | 2020-11-19 |
20200360484 | NDP-MSH FOR TREATMENT OF INFLAMMATORY AND/OR NEURODEGENERATIVE DISORDERS OF THE CNS | 2020-11-19 |
20200360485 | MODIFIED RELAXIN POLYPEPTIDES AND THEIR USES | 2020-11-19 |
20200360486 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC COMPLICATIONS | 2020-11-19 |
20200360487 | PTH PRODRUGS | 2020-11-19 |
20200360488 | PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS | 2020-11-19 |
20200360489 | HUMAN ALPHA-GALACTOSIDASE VARIANTS | 2020-11-19 |
20200360490 | HUMAN ALPHA-GALACTOSIDASE VARIANTS | 2020-11-19 |
20200360491 | TREATMENT OF LYSOSOMAL STORAGE DISEASE IN THE EYE THROUGH ADMINISTRATION OF AAVS EXPRESSING TPP1 | 2020-11-19 |
20200360492 | INJECTION PARADIGM FOR ADMINISTRATION OF BOTULINUM TOXINS | 2020-11-19 |
20200360493 | Compositions and Methods for Treating Cancer with Arginine Depletion and Immuno Oncology Agents | 2020-11-19 |
20200360494 | METHOD OF MAKING PDIA2 AND COMPOSITIONS CONTAINING PDIA2 | 2020-11-19 |
20200360495 | METHODS OF TREATING ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR | 2020-11-19 |
20200360496 | NOVEL COMPOSITION AND USE THEREOF | 2020-11-19 |
20200360497 | COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELLS | 2020-11-19 |
20200360498 | VACCINE COMPOSITIONS FOR USE AGAINST DIGITAL DERMATITIS IN A MAMMAL | 2020-11-19 |
20200360499 | CDKN2a Companion Diagnostic for Bladder Cancer Interferon Therapy | 2020-11-19 |
20200360500 | PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS | 2020-11-19 |
20200360501 | Dimethyl Fumarate and Vaccination Regimens | 2020-11-19 |
20200360502 | MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSTION | 2020-11-19 |
20200360503 | NEISSERIA MENINGITIDES IMMUNOGENIC COMPOSITIONS | 2020-11-19 |
20200360504 | PSEUDOMONAS ANTIGENS AND ANTIGEN COMBINATIONS | 2020-11-19 |
20200360505 | Zika Vaccines and Immunogenic Compositions, and Methods of Using the Same | 2020-11-19 |
20200360506 | VACCINE AGAINST RSV | 2020-11-19 |
20200360507 | INFLUENZA VACCINE | 2020-11-19 |
20200360508 | H7 Avian Influenza Vaccine Strain which Differentiates Infected from Vaccinated Animals, Preparation Method Therefor, and Application | 2020-11-19 |
20200360509 | EXPRESSION SYSTEMS | 2020-11-19 |
20200360510 | FORMULATIONS FOR VIROSOMES | 2020-11-19 |
20200360511 | ALUMINUM COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES | 2020-11-19 |
20200360512 | MOLECULAR ADJUVANT AND VACCINE | 2020-11-19 |
20200360513 | NANOFIBER COMPOSITIONS FOR A VACCINE ADJUVANT, POROUS SCAFFOLD OR POROUS MEMBRANE | 2020-11-19 |
20200360514 | A NOVEL VACCINE ADJUVANT | 2020-11-19 |
20200360515 | NANOCAPSULE-BASED OCULAR THERAPY | 2020-11-19 |
20200360516 | TRACE ELEMENTS | 2020-11-19 |
20200360517 | NUTRITIONAL COMPOSITION | 2020-11-19 |
20200360518 | ENGINEERED MICROPARTICLES FOR MACROMOLECULE DELIVERY | 2020-11-19 |
20200360519 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF POSTOPERATIVE PAIN | 2020-11-19 |
20200360520 | USE OF RIFAMYCIN-QUINOLIZIDONE COUPLING MOLECULE | 2020-11-19 |
20200360521 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | 2020-11-19 |
20200360522 | NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING SAME, PREPARATION METHOD, AND USE THEREOF | 2020-11-19 |
20200360523 | ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS | 2020-11-19 |
20200360524 | AMINOGLYCOSIDE DERIVATIVES AND NANO-ASSEMBLIES THEREOF, INCLUDING THOSE WITH QUORUM SENSING INHIBITORY FUNCTION | 2020-11-19 |
20200360525 | Modified Relaxin Polypeptides and Their Uses | 2020-11-19 |
20200360526 | PHOSPHOALKYL POLYMERS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS | 2020-11-19 |
20200360527 | Molecular-Size of Elastin-Like Polypeptide Delivery System for Therapeutics Modulates Intrarenal Deposition and Bioavailability | 2020-11-19 |
20200360528 | Compositions Having Antifungal Activity | 2020-11-19 |
20200360529 | PEPTIDIC MATERIALS THAT TRAFFIC EFFICIENTLY TO THE CELL CYTOSOL AND NUCLEUS | 2020-11-19 |
20200360530 | FGF21 C-TERMINAL PEPTIDE OPTIMIZATION | 2020-11-19 |
20200360531 | ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS | 2020-11-19 |
20200360532 | PROCESS FOR THE PREPARATION OF DRUG LINKER COMPOUNDS | 2020-11-19 |
20200360533 | Simian Adenovirus and Hybrid Adenoviral Vectors | 2020-11-19 |
20200360534 | GENE THERAPY FOR LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 2C | 2020-11-19 |
20200360535 | METHODS OF IMPROVING ADENO-ASSOCIATED VIRAL TRANSDUCTION | 2020-11-19 |
20200360536 | TREATMENT OF HEART DISEASE BY DISRUPTION OF THE ANCHORING OF PP2A | 2020-11-19 |
20200360537 | A GANGLIOGLIOMA-INDUCED ANIMAL MODEL AND A METHOD FOR DIAGNOSING AND TREATING GANGLIOGLIOMA AND RELATED DISEASES | 2020-11-19 |
20200360538 | METHODS OF CANCER DETECTION USING PARPI-FL | 2020-11-19 |
20200360539 | ALTERNATING CURRENT MAGNET SYSTEM FOR MAGNET-ASSISTED TRANSFECTION | 2020-11-19 |
20200360540 | FREEZE-DRIED PRODUCT AND GAS-FILLED MICROVESICLES SUSPENSION | 2020-11-19 |
20200360541 | ELECTROCHEMICAL FLASH FLUORINATION AND RADIOFLUORINATION | 2020-11-19 |
20200360542 | SCAFFOLDS AND MULTIFUNCTIONAL INTERMEDIATES FOR IMAGING PSMA AND CANCER THERAPY | 2020-11-19 |
20200360543 | RADIOTRACERS FOR IMAGING ER-POSITIVE BREAST CANCER | 2020-11-19 |